What is HYCOR Biomedical?
Founded in 1981, HYCOR Biomedical is a globally recognized manufacturer and supplier of in-vitro diagnostics products. The company specializes in allergy and autoimmune testing solutions, serving clinical laboratories, hospitals, and physicians' offices worldwide. HYCOR Biomedical's commitment to advancing diagnostic capabilities positions it as a key player in the healthcare technology sector.
How much funding has HYCOR Biomedical raised?
HYCOR Biomedical has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in HYCOR Biomedical
PPP
Public-Private Partnership
What's next for HYCOR Biomedical?
The substantial enterprise-level funding and recent strategic investment indicate a strong growth phase for HYCOR Biomedical. This capital infusion is likely to fuel further research and development, expansion of manufacturing capabilities, and broader market penetration for its diagnostic products. The company is poised to enhance its offerings in allergy and autoimmune diagnostics, reinforcing its market leadership.
See full HYCOR Biomedical company page